The legendary “Wolverine Stack” — the most popular recovery combination for comprehensive tissue healing.
The BPC-157 / TB-500 combination, often called the “Wolverine Stack,” is the most popular recovery protocol in the peptide community. BPC-157 provides local tissue repair and angiogenesis while TB-500 provides systemic healing through actin regulation. Together they cover both local and systemic healing pathways.
Subcutaneous injection
BPC-157: 500 mcg + TB-500: 2.5 mg
BPC-157: daily; TB-500: 2x/week
“The legendary “Wolverine Stack” — the most popular recovery combination for comprehensive tissue healing.”
BPC-157 activates the FAK-paxillin pathway and promotes local angiogenesis for targeted tissue repair. TB-500 regulates G-actin sequestration for systemic cell migration and repair. The combination provides complementary local + systemic healing coverage.
BPC-157: 500 mcg + TB-500: 2.5 mg
6–8 weeks
Subcutaneous injection
Inject BPC-157 near injury site for local effects. TB-500 can be injected anywhere subcutaneously. Both can be injected simultaneously in separate sites.
Per individual vial or blend reconstitution instructions.
Lyophilized: refrigerate. Reconstituted: refrigerate and use within 30 days.
When sourcing BPC-157 / TB-500 for research purposes, the following quality benchmarks should be verified before use.
>98% (verified by HPLC)
Must be provided by supplier
<0.1 EU/mg (prevents bacterial contamination)
Manufactured in cGMP-certified facility
Independent lab verification preferred
Lyophilized: refrigerate. Reconstituted: refrigerate and use within 30 days.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
Multiple animal studies and/or early human trials. Reasonable confidence in mechanism, but human data is limited.
Peptides commonly used alongside BPC-157 / TB-500 for synergistic effects.
A short-acting GHRH analog that produces physiological GH pulses when combined with a GHRP like Ipamorelin.
The most selective GHRP available, stimulating GH release with minimal cortisol or prolactin elevation.
Category
Status
Dose
BPC-157: 500 mcg + TB-500: 2.5 mg
Frequency
BPC-157: daily; TB-500: 2x/week
Cycle
6–8 weeks
Peptides
Protocols
Other Pages
Contact Us Today!
© 2026 Best Health IQ. All rights reserved.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many compounds described on this site are not approved by the FDA for human therapeutic use. Some are available only as compounded preparations or as materials sold for laboratory use, and several are on FDA's Category 2 list for significant safety risks. Nothing on this site constitutes medical advice or a recommendation to use any compound described.
